Follistatin-344

Follistatin-344 (also known as FS-344) is a prominently researched experimental compound classified strictly within the Myostatin Inhibitor framework. Operating primarily through advanced pharmacological pathways, it functions by blocks myostatin (the body's muscle growth limiter) and activin, allowing enhanced muscle development and regeneration beyond normal physiological limits. with a documented biological half-life of roughly 6 hours, in preclinical investigative trials and independent academic studies, researchers utilizing Follistatin-344 have documented significant, quantifiable biological outcomes, primarily focusing on muscle hypertrophy, strength. Typical research protocols investigate administering 100 to 100mcg via subq pathways 7x/wk. However, it is critically important to understand that while Follistatin-344 demonstrates profound physiological potential in highly controlled laboratory settings, it remains classified strictly as a research chemical and has not been approved by the United States Food and Drug Administration (FDA) for human therapeutic, diagnostic, or dietary consumption. Independent chemical analysis via rigorous third-party Certificate of Analysis (COA) testing utilizing High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) remains the industry gold standard for verifying its base elemental stability when reconstituted appropriately in sterile bacteriostatic water.